Nuwellis names Mike McCormick as CEO effective June 30, 2026, with John Erb staying as Chairman.

Nuwellis, a medical technology firm focused on cardiorenal care, appointed Mike McCormick as CEO starting June 30, 2026. Current CEO John Erb will step down from his executive role but remain Chairman of the Board. McCormick brings over 30 years of experience in medical technology and aims to advance Nuwellis' growth, commercial execution, and product pipeline. This leadership change signals a strategic move to strengthen the company's position in precision fluid management for cardiorenal patients.